Fixed airflow obstruction relates to eosinophil activation in asthmatics.
Ida MogensenKjell AlvingSven-Erik DahlenAnna JamesBertil ForsbergJunya OnoShoichiro OhtaPer VengeMagnus P BorresKenji IzuharaChrister JanssonAndrei MalinovschiPublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2018)
These findings support that type 2 inflammation, and in particular eosinophil inflammation, is found in asthma with fixed-AO. This could indicate a benefit from eosinophil-directed therapies. Further longitudinal studies are warranted to investigate causality and relation to lung function decline.